Cancer Center

Terramed Alliance News Safe To Treat HER2-positive Breast Cancer

Standard adjuvant treatment for HER2-positive breast cancer patients, following primary surgery for their cancer, is Trastuzumab (Herceptin)–typically used in combination with chemotherapy. However, a new study by researchers at Fox Chase Cancer Center reports that it may be safe to treat these patients with both Trastuzumab and adjuvant radiation therapy.

The study will be presented at the annual meeting of the American Society for Radiation Oncology (ASTRO).

Anti-Estrogens May Offer Protection Against Lung Cancer Mortality

“We found a reduction in lung cancer mortality among women treated with anti-estrogens for breast cancer. This work builds on previous studies that had suggested estrogens have a role in lung cancer development and progression,” said Elisabetta Rapiti, M.D., M.P.H., medical researcher with the Geneva Cancer Registry, University of Geneva, Switzerland.

Rapiti and colleagues evaluated whether anti-estrogen therapy for breast cancer patients reduced their risk of subsequently developing and/or dying from lung cancer.

Gene linked to kidney cancer in children discovered

Gene linked to kidney cancer in children discovered
Cancer Research UK-funded scientists have identified two genes linked to Wilms’ tumour – a type of childhood kidney cancer – according to research published in Clinical Cancer Research.

Cancer Center

Terramed Alliance News Safe To Treat HER2-positive Breast Cancer

Related posts

Anti-Estrogens May Offer Protection Against Lung Cancer Mortality

Related posts

Gene linked to kidney cancer in children discovered

Related posts